Abstract
Urticaria and angioedema will affect 15% of the general population during their lifetime, and this remains one of the most vexing cutaneous conditions to evaluate and treat. Patients frequently go from one physician to another in hopes of finding a healthcare provider who can identify the cause and cure the ailment. Physicians treating hives are equally frustrated as they ponder the utility of obtaining a panel of screening laboratory tests that have previously been shown to have a low yield or obtaining selected allergy tests in a group of patients who are no more prone to allergic disease than the general public. This review presents recent information in a clinical context with the aim of aiding the physician in understanding the pathophysiology of urticaria and formulating an intelligent evaluation and treatment plan.
Similar content being viewed by others
References and Recommended Reading
Charlesworth EN, Hood AF, Soter NA, et al.: Cutaneous late-phase response to allergen: mediator release and inflammatory cell infiltration. J Clin Invest 1989, 83:1519–1526.
Grattan CE, Wallington TB, Warin RP, et al.: A serological mediator in chronic idiopathic urticaria: a clinical immunological and histological evaluation. Br J Dermatol 1986, 114:583–590.
Hide M, Francis DM, Grattan CE, Greaves MW: Autoantibodies against the high affinity IgE receptor as a cause for histamine release in chronic urticaria. N Engl J Med 1993, 328:1599–1604.
Nimi N, Francis DM, Kermani F, et al.: Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996, 106:1001–1006.
Fiebiger E, Maurer D, Holub H, et al.: Serum IgG autoantibodies directed against the alpha chain of the FceRI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria: a pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest 1995, 96:2606–2612.
Sabroe RA, Poon E, Orchard GE, et al.: Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FceRIa or anti-IgE autoantibodies. J Allergy Clin Immunol 1999, 103:484–493.
Charlesworth EN: Urticaria and angioedema: a clinical spectrum. Ann Allergy Asthma Immunol 1996, 76:484–496.
Zavadak D, Tharp MD: Chronic urticaria as a manifestation of the late phase reaction. In Immunology and Allergy Clinics of North America. Edited by Charlesworth EN. Philadelphia: WB Saunders; 1995:745–759.
Jarisch R, Beringer K, Hemer W: Role of food allergy and food intolerance in recurrent urticaria. Curr Probl Dermatol 1998, 28:64–73.
Castillo R, Delgado J, Quiralte J, et al.: Food hypersensitivity among adult patients: epidemiological and clinical aspects. Allergol Immunopathol (Madr) 1996, 24:93–97.
Greaves M: Chronic urticaria. J Allergy Clin Immunol 2000, 105:644–672. This "state-of-the-art" review of urticaria should be in every physician’s reference library.
Greaves MW: Chronic urticaria. N Engl J Med 1995, 332:1767–1772.
Charlesworth EN: The spectrum of urticaria. In Immunology and Allergy Clinics of North America. Edited by Charlesworth EN. Philadelphia: WB Saunders; 1995:641–657.
Mathews KP: Urticaria and angioedema. J Allergy Clin Immunol 1983, 72:1–14.
Kaplan AP: Urticaria and angioedema. In Allergy: Principles and Practice edn 5. Edited by Middleton E, Reed CE, Ellis EF, et al. St. Louis: Mosby; 1988:1104–1122.
Venzor J, Baer SC, Huston DP: Urticaria vasculitis. In Immunology and Allergy Clinics of North America. Edited by Charlesworth EN. Philadelphia: WB Saunders; 1995:761–774.
Aboobaker J, Greaves MW: Urticarial Vasculitis. Clin Exp Dermatol 1986, 11:436–444.
McDuffie FC, Sams WM Jr, Maldano JE: Hypocomplementemia with cutaneous vasculitis and arthritis: possible immune complex syndrome. Mayo Clin Proc 1973, 48:340–348.
Soter NA: Chronic urticaria as a manifestation of necrotizing venulitis. N Engl J Med 1977, 296:1440–1442.
Millar MM, Patterson R: A patient referred for evaluation of angioedema. Ann Allergy Asthma Immunol 1998, 81:120–126.
Brown NJ, Snowden M, Griffin MR: Recurrent angiotensinconverting enzyme inhibitor associated angioedema. JAMA 1997, 278:232–233.
Cicardi M, Agostoni A: Hereditary angioedema. N Engl J Med, 1996:1666–1667.
Cicardi M, Bergamaschini L, Cugno M, et al.: Pathogenetic and clinical aspects of C1 inhibitor deficiency. Immunobiology 1998, 199:366–376.
Kennard CD: Evaluation and treatment of urticaria. In Immunology and Allergy Clinics of North America. Edited by Charlesworth EN. Philadelphia: WB Saunders; 1995:785–801.
O’Hanlon JF: Antihistamine effects on actual driving performance in a standard test: a summary of the Dutch experience: 1989–1994. Allergy 1995, 50:234–242.
Gengo FM, Manning C: A review of the effects of antihistamines on mental processes related to automobile driving. J Allergy Clin Immunol 1990, 186:1034–1039.
Adelsberg BR, D’Amico-Beadone A: The effects of loratadine, diphenhydramine and placebo on worker productivity: results of a double blind trial. J Allergy Clin Immunol 1990, 85:296.
Kay GG, et al.: Self-reported sedation doesn’t predict impaired CNS functioning after dose of sedating antihistamine. J Allergy Clin Immunol 1999, 103:S254.
Paul E: Loratadine and terfenadine in the treatment of chronic urticaria. Allergy 1988, 43(suppl 7):122.
Shareeah AMA: Comparative efficacy of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Int J Dermatol 1992, 331:355–356.
Charlesworth EN, Massey WA, Kagey-Sobotka A, et al.: Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992, 262:964–970.
Commens CA, Greaves MW: Cimetidine in chronic idiopathic urticaria: a randomized double-blind study. Br J Dermatol 1978, 99:675–676.
Thomas SE, Glenny H, Bleechen SS, et al.: Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. Br J Dermatol 1987, 117:81–88.
Spector SL: Antileukotrienes in chronic urticaria [letter]. J Allergy Clin Immunol 1998, 101:572.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Charlesworth, E.N. Chronic urticaria: Background, evaluation, and treatment. Curr Allergy Asthma Rep 1, 342–347 (2001). https://doi.org/10.1007/s11882-001-0046-y
Issue Date:
DOI: https://doi.org/10.1007/s11882-001-0046-y